Takeda Pharmaceutical Co Ltd
TSE:4502
Takeda Pharmaceutical Co Ltd
Tax Provision
Takeda Pharmaceutical Co Ltd
Tax Provision Peer Comparison
Competitive Tax Provision Analysis
Latest Figures & CAGR of Competitors
Company | Tax Provision | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Takeda Pharmaceutical Co Ltd
TSE:4502
|
Tax Provision
¥30.1B
|
CAGR 3-Years
-21%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Daiichi Sankyo Co Ltd
TSE:4568
|
Tax Provision
-¥12.7B
|
CAGR 3-Years
-7%
|
CAGR 5-Years
3%
|
CAGR 10-Years
7%
|
|
Otsuka Holdings Co Ltd
TSE:4578
|
Tax Provision
-¥17.2B
|
CAGR 3-Years
23%
|
CAGR 5-Years
7%
|
CAGR 10-Years
13%
|
|
Eisai Co Ltd
TSE:4523
|
Tax Provision
-¥24.4B
|
CAGR 3-Years
-15%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
-2%
|
|
Chugai Pharmaceutical Co Ltd
TSE:4519
|
Tax Provision
-¥118.3B
|
CAGR 3-Years
-12%
|
CAGR 5-Years
-33%
|
CAGR 10-Years
-17%
|
|
Astellas Pharma Inc
TSE:4503
|
Tax Provision
-¥35.3B
|
CAGR 3-Years
-3%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
-2%
|
See Also
What is Takeda Pharmaceutical Co Ltd's Tax Provision?
Tax Provision
30.1B
JPY
Based on the financial report for Dec 31, 2023, Takeda Pharmaceutical Co Ltd's Tax Provision amounts to 30.1B JPY.
What is Takeda Pharmaceutical Co Ltd's Tax Provision growth rate?
Tax Provision CAGR 3Y
-21%
Over the last year, the Tax Provision growth was 2 051%. The average annual Tax Provision growth rates for Takeda Pharmaceutical Co Ltd have been -21% over the past three years .